瘤学中的生物标志物:生物标志物驱动研究和统计分析的复杂性
Hajime Uno1,2,3, Miki Horiguchi1,2,4
1Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
基于生物标志物的试验对于精确瘤学至关重要,使得有针对性的治疗成为可能. 然而,这些试验在设计和数据分析方面存在独特的挑战.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 临床试验设计 临床试验设计
背景情况:
- 精确瘤学依赖于生物标志物驱动的临床试验,以匹配患者的向疗法.
- 识别和验证预测生物标志物对于治疗疗效至关重要.
更多相关视频
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
相关概念视频
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Statistical Methods for Analyzing Epidemiological Data
Kaplan-Meier Approach
Assumptions of Survival Analysis
